Capricor Therapeutics Stock In The News
| CAPR Stock | USD 18.62 0.83 4.67% |
Our overall analysis of Capricor Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Capricor Therapeutics. The specific impact of Capricor Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Capricor Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Capricor Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Capricor Therapeutics Backtesting and Capricor Therapeutics Hype Analysis. To learn how to invest in Capricor Stock, please use our How to Invest in Capricor Therapeutics guide.
Capricor |
Capricor Therapeutics Today Top News and Investor Outlook
Capricor Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Capricor and other traded companies coverage with news coverage. We help investors stay connected with Capricor headlines for the 23rd of November to make an informed investment decision based on correlating the impacts of news items on Capricor Stock performance. Please note that trading solely based on the Capricor Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Capricor Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Capricor earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Capricor Therapeutics that are available to investors today. That information is available publicly through Capricor media outlets and privately through word of mouth or via Capricor internal channels. However, regardless of the origin, that massive amount of Capricor data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Capricor Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Capricor Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Capricor Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Capricor Therapeutics alpha.
Capricor Largest EPS Surprises
Earnings surprises can significantly impact Capricor Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-11-12 | 2020-09-30 | -0.18 | -0.2 | -0.02 | 11 | ||
2022-11-10 | 2022-09-30 | -0.29 | -0.26 | 0.03 | 10 | ||
2023-11-14 | 2023-09-30 | -0.29 | -0.25 | 0.04 | 13 | ||
2022-08-10 | 2022-06-30 | -0.25 | -0.29 | -0.04 | 16 | ||
2021-11-09 | 2021-09-30 | -0.22 | -0.17 | 0.05 | 22 | ||
2023-08-07 | 2023-06-30 | -0.35 | -0.29 | 0.06 | 17 |
Capricor Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Capricor Therapeutics Stock. Current markets are strongly bullish. About 82% of major world exchanges and indexes are currently up. See today's market update for more information.
20th of November 2024
Parent Project Muscular Dystrophy Culminates 30th Anniversary with Celebratory Investing i... at finance.yahoo.com
15th of November 2024
Capricor Therapeutics, Inc. Q3 2024 Earnings Call Transcript at insidermonkey.com
13th of November 2024
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate ... at finance.yahoo.com
12th of November 2024
Capricor Therapeutics Q3 2024 Earnings Preview at seekingalpha.com
7th of November 2024
Is Capricor Therapeutics Outperforming Other Medical Stocks This Year at zacks.com
6th of November 2024
Verano Holdings Corp. Expected to Beat Earnings Estimates Should You Buy at finance.yahoo.com
5th of November 2024
Earnings Preview Capricor Therapeutics Q3 Earnings Expected to Decline at finance.yahoo.com
30th of October 2024
Capricor Therapeutics Inc Short Interest Up 17.9 percent in October at thelincolnianonline.com
17th of October 2024
Why Capricor Therapeutics Shares Are Trading Lower at benzinga.com
1st of October 2024
Capricor Therapeutics Is Up Over 100, Could Rise Even Higher at benzinga.com
17th of September 2024
Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion... at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Capricor Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Capricor Therapeutics' short interest history, or implied volatility extrapolated from Capricor Therapeutics options trading.
Additional Tools for Capricor Stock Analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.